We are excited to be partnering with Iylon Precision Oncology. The US-based company works with experts from around the world to create a personalised, evidence-based and optimised treatment recommendation for each patient. In future, they will also use our innovative product services based on molecular and cell analyses for their recommendations.
Prof Sendurai Mani, co-founder of Iylon Precision Oncology, sums up the partnership as follows:
“Iylon’s clinical advisors are globally renowned experts in Precision Oncology and together with Iylon’s own in-house experts and Datar’s diagnostic tools, patients can look forward to best chance at being cancer-free.”